Maxim Kobelev
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Prostate Cancer Treatment and Research
Papers in
-
- Mechanisms of cancer metastasis 2
- Genomics and Chromatin Dynamics 1
- Ubiquitin and proteasome pathways 1
- Epigenetics and DNA Methylation 1
- FOXO transcription factor regulation 1
- Protein Degradation and Inhibitors 1
-
- Prostate Cancer Treatment and Research 3
- Co-authors
- Amina Zoubeidi (5 shared papers)Yuzhuo Wang (1 shared paper)Mannan Nouri (1 shared paper)Dong Lin (1 shared paper)Colin C. Collins (1 shared paper)Elai Davicioni (1 shared paper)Ralph Buttyan (1 shared paper)Ewan A. Gibb (1 shared paper)
- Journals
- European Urology (1 paper)Nature Communications (1 paper)The Journal of Urology (1 paper)EMBO Molecular Medicine (1 paper)JCI Insight (1 paper)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
Maxim Kobelev
5 papers receiving 159 citations
Peers
Comparison fields: 5 of 22
- Cancer Research 87
- Pulmonary and Respiratory Medicine 67
- Molecular Biology 93
- Oncology 26
- Geriatrics and Gerontology 2
Countries citing papers authored by Maxim Kobelev
This map shows the geographic impact of Maxim Kobelev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim Kobelev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim Kobelev more than expected).
Fields of papers citing papers by Maxim Kobelev
This network shows the impact of papers produced by Maxim Kobelev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim Kobelev. The network helps show where Maxim Kobelev may publish in the future.
Co-authors
The 21 scholars most cited alongside Maxim Kobelev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 82 | |
| 2 | 2022 | 70 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 1 | |
| 5 | 2025 | 1 |
About Maxim Kobelev
Maxim Kobelev is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Infectious Diseases, having authored 5 papers that have together received 160 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Mechanisms of cancer metastasis (2 papers), Genomics and Chromatin Dynamics (1 paper), Ubiquitin and proteasome pathways (1 paper), Epigenetics and DNA Methylation (1 paper), FOXO transcription factor regulation (1 paper), Protein Degradation and Inhibitors (1 paper) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Cancer Research (87 citations), Pulmonary and Respiratory Medicine (67 citations), Molecular Biology (93 citations), Oncology (26 citations) and Geriatrics and Gerontology (2 citations). Maxim Kobelev has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Amina Zoubeidi, Yuzhuo Wang, Mannan Nouri, Dong Lin, Colin C. Collins, Elai Davicioni, Ralph Buttyan, Ewan A. Gibb, Varune Rohan Ramnarine and Takeshi Namekawa. Their work appears in journals such as European Urology, Nature Communications, The Journal of Urology, EMBO Molecular Medicine and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.